Image

    Finasteride Inhibits Melanogenesis Through Regulation of the Adenylate Cyclase in Melanocytes and Melanoma Cells

    February 2018 in “ Archives of Pharmacal Research
    Jae Hong Seo, Silvia Yumnam, Kwang-Yong Jeong, Sun Yeou Kim
    Studysummary This study found that finasteride decreases melanin levels in melanocyte and melanoma cells by inhibiting MC1R, without causing cytotoxicity, suggesting its potential role in regulating melanogenesis.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 7

    1. Testosterone Regulates Levels of Cystic Fibrosis Transmembrane Regulator, Adenylate Cyclase, and cAMP in the Seminal Vesicles of Orchidectomized Rats Theriogenology · 2015
    2. A Review of Medical and Surgical Treatment Options for Androgenetic Alopecia JAMA Facial Plastic Surgery · 2014
    3. The Efficacy and Safety of 5α-Reductase Inhibitors in Androgenetic Alopecia: A Network Meta-Analysis and Benefit–Risk Assessment of Finasteride and Dutasteride Journal of Dermatological Treatment · 2013
    4. Key Targets of Hormonal Treatment of Prostate Cancer: The Androgen Receptor and 5α-Reductase BJU international · 2009
    5. A New Look at the 5-Alpha-Reductase Inhibitor Finasteride Cns Drug Reviews · 2006
    6. Local and Systemic Reduction by Topical Finasteride or Flutamide of Hamster Flank Organ Size and Enzyme Activity Journal of Investigative Dermatology · 1995
    7. The Effect of Finasteride in Men with Benign Prostatic Hyperplasia The New England Journal of Medicine · 1992

    Related research 1

    1. Finasteride Inhibits Melanogenesis Through Regulation of the Adenylate Cyclase in Melanocytes and Melanoma Cells Archives of Pharmacal Research · 2018